Fate Therapeutics
FATE
#8582
Rank
S$0.35 B
Marketcap
S$2.93
Share price
-5.76%
Change (1 day)
60.53%
Change (1 year)

Market capitalization of Fate Therapeutics (FATE)

Market cap: S$0.35 Billion

As of October 2026 Fate Therapeutics has a market cap of S$0.35 Billion. This makes Fate Therapeutics the world's 8582th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Fate Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026S$0.35 B136.88%
2025S$0.14 B-40.58%
2024S$0.24 B-48.82%
2023S$0.48 B-62.95%
2022S$1.31 B-82.6%
2021S$7.55 B-28.03%
2020S$10.49 B425.26%
2019S$1.99 B76.21%
2018S$1.13 B163.6%
2017S$0.43 B186.13%
2016S$0.15 B9.83%
2015S$0.13 B0.13%
2014S$0.13 B-15.91%
2013S$0.16 B

End of Day market cap according to different sources

On Oct 6th, 2026 the market cap of Fate Therapeutics was reported to be:

S$0.35 Billion
by Nasdaq info icon info icon
S$0.35 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Becton Dickinson
BDX
S$62.79 B 17,798.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
S$2.33 B 566.35%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
S$6.79 B 1,837.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$18.91 B 5,290.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
S$14.38 B 3,999.71%๐Ÿ‡บ๐Ÿ‡ธ USA